Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
28,000
Employees28,000
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
28,000
Employees28,000

AMGN Key Statistics

Market cap
157.85B
Market cap157.85B
Price-Earnings ratio
23.87
Price-Earnings ratio23.87
Dividend yield
3.22%
Dividend yield3.22%
Average volume
1.82M
Average volume1.82M
High today
$294.56
High today$294.56
Low today
$287.25
Low today$287.25
Open price
$290.58
Open price$290.58
Volume
576.34K
Volume576.34K
52 Week high
$335.88
52 Week high$335.88
52 Week low
$253.30
52 Week low$253.30

AMGN News

Simply Wall St 10h
Evaluating Amgen: Is Current Valuation Attractive After Recent 1-Month Momentum?

Amgen (AMGN) shares have generally moved sideways over the past month, with investors weighing recent financial performance and sector trends. The stock remains...

Evaluating Amgen: Is Current Valuation Attractive After Recent 1-Month Momentum?
Simply Wall St 2d
Is Amgen Poised for Growth After Recent 4% Price Dip?

If you have been debating whether Amgen deserves a place in your portfolio, you are not alone. The last few months have kept investors guessing, with a 6.7% pri...

Is Amgen Poised for Growth After Recent 4% Price Dip?
Nasdaq 2d
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's ear...

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Analyst ratings

48%

of 33 ratings
Buy
42.4%
Hold
48.5%
Sell
9.1%

More AMGN News

TipRanks 3d
Amgen’s Promising Phase 3 Study on Blinatumomab for Leukemia: What Investors Need to Know

Amgen Inc ((AMGN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...

TipRanks 3d
Amgen’s Avacopan Study: A Closer Look at Long-term Safety in ANCA-associated Vasculitis

Amgen Inc ((AMGN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...

TipRanks 3d
Amgen’s Tarlatamab Study: A Potential Game-Changer in Lung Cancer Treatment

Amgen Inc ((AMGN)), BeOne Medicines ((ONC)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks P...

TipRanks 3d
Amgen’s ABP 234 vs. Keytruda: A New Hope for Lung Cancer Treatment?

Amgen Inc ((AMGN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...

TipRanks 3d
Amgen’s CodeBreaK 202: A New Frontier in Lung Cancer Treatment

Amgen Inc ((AMGN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...

TipRanks 3d
Amgen’s Apremilast Study: A Potential Game-Changer for Pediatric Behçet’s Disease

Amgen Inc ((AMGN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...

TipRanks 3d
Amgen’s Innovative Study on AMG 193: A Potential Game-Changer in Cancer Treatment

Amgen Inc ((AMGN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock...

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.